Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | SHBG | P04278 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 7/20 | 0.47 |
| ▸ | CA1 | P00915 | 6/20 | 0.47 |
| ▸ | CA9 | Q16790 | 6/20 | 0.47 |
| ▸ | CA12 | O43570 | 4/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30751605 | 1.00 | CYP3A4 (0.55) | CYP3A4NPC1RAB9ACYP1A2CYP2C9 | |
| SCHEMBL30751604 | 1.00 | CYP3A4 (0.55) | CYP3A4NPC1RAB9ACYP1A2CYP2C9 | |
| SCHEMBL12446356 | 1.00 | CYP3A4 (0.55) | CYP3A4NPC1RAB9ACYP1A2CYP2C9 | |
| SCHEMBL30894527 | 1.00 | CYP3A4 (0.55) | CYP3A4NPC1RAB9ACYP1A2CYP2C9 | |
| SCHEMBL28044264 | 1.00 | CYP3A4 (0.55) | CYP3A4NPC1RAB9ACYP1A2CYP2C9 | |
| SCHEMBL30751607 | 1.00 | CYP3A4 (0.55) | CYP3A4NPC1RAB9ACYP1A2CYP2C9 | |
| SCHEMBL7439981 | 0.87 | CYP3A4 (0.62) | CYP3A4NPC1RAB9ACYP1A2CYP2C9 | |
| SCHEMBL7432864 | 0.87 | CYP3A4 (0.62) | CYP3A4NPC1RAB9ACYP1A2CYP2C9 | |
| SCHEMBL6832312 | 0.87 | ALDH1A1 (0.56) | NPC1RAB9ASMN1; SMN2MAPTMEN1 | |
| SCHEMBL11310048 | 0.79 | EED (0.50) | MAPTLMNAALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250059219-A1 | LIGNAN DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2025-02-20 | — | — | US | disclosed |
| CN-117440947-A | Lignan derivative, preparation method and application thereof | 中国科学院上海药物研究所 | 2024-01-23 | — | — | CN | disclosed |
| WO-2022222686-A1 | LIGNAN DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | 中国科学院上海药物研究所 | 2022-10-27 | — | — | WO | disclosed |
| CN-115215821-A | Lignan derivative, preparation method and application thereof | 中国科学院上海药物研究所 | 2022-10-21 | — | — | CN | disclosed |
| CN-105175365-B | A kind of method of the β benzyl butyrolactone efficiently synthesized with particular configuration | 辽宁中医药大学 | 2018-03-06 | — | — | CN | disclosed |
| CN-105175365-A | Method for efficiently synthesizing beta-benzyl butyrolactone having specific configuration | UNIV LIAONING TRAD CHINESE MED | 2015-12-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250059219-A1 | LIGNAN DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | HADHA, HADHB, HADH | CYP3A4 272/4885NPC1 1672/4885RAB9A 4549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.